All-trans retinoic acid (ATRA), an active metabolite of
retinal, has been shown to exert anti-
cancer activities in a number of
cancer cells and tissues.
Syndecan-1 is a
proteoglycan, mediate cell-cell adhesion and prevent invasion in epithelial cells. The aim of the present study was to examine the level of
syndecan-1 expression and the chemopreventive effect of ATRA during
lung cancer development in BALB/c mice.
Syndecan-1 expression was examined by immunohistochemistry using mouse monoclonal anti-human
syndecan-1 antibody. In this study, benzo(α)
pyrene [B(α)P] was used to induce
lung cancer. The results indicated that ATRA has anti-
cancer effect against B(α)P-induced lung
tumor development as induced by number of
tumor nodules and histopathologic report. The loss of
syndecan-1 expression in the epithelial cell membrane is associated with
tumor cell growth and invasiveness. Our study for
syndecan-1 indicated a chemoprotective effect of ATRA against changes in lung epithelial cell membrane
syndecan-1 expression in B(α)P-induced
lung cancer model. Therefore ATRA could serve as effective chemotherapeutic agent against
cancer invasion/
metastasis, at least in the lungs.